References
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53
- Wedisinghe L, Perera M. Diabetes and menopause. Maturitas 2009;63:200–3
- Liao S, Li J, Wei W, et al. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev 2011;12:1061–5
- Roglic G. Diabetes in women: the global perspective. Int J GynaecolObstet 2009;104(Suppl 1):S11–13
- Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) 2011;203:259–69
- Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 2009;5: 553–8
- Kim C. Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women.Women's Health (Lond Engl) 2012;8:155–67
- Khoo CL, Perera M. Diabetes and the menopause. J Br Menopause Soc 2005;11:6–11
- Progetto Menopausa Italia Study Group. General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy. Menopause 2001; 8:290–5
- National Center for Health Statistics. Healthy people 2010. Final review. http://www.cdc.gov/nchs/data/hpdata2010/hp2010_final_review.pdf. Accessed: 14/04/2013
- World Medical Association. Declaration of Helsinki. JAMA 1997;277:925–6
- CEPAL-ECLAC. Statistical Yearbook for Latin America and the Caribbean 2010. Santiago, Chile: United Nations Publication, 2011
- Organización Panamericana de la Salud. Guías ALAD de Diagnóstico, Control y Tratamiento de Diabetes Mellitus Tipo II. Washington, DC: OPS, 2008:9
- CEPAL. Panorama Social de América Latina. 2012. http://www.eclac.org/publicaciones/xml/5/48455/PanoramaSocial2012DocI-Rev.pdf. Accessed: 14/04/2013
- Soules MR, Sherman S, Parrott E, et al. Executive Summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267–72
- Heinemman K, Ruebig A, Potthof P. The menopause rating scale (MRS): A methodological review. Qual Life Res 2004; 2:45
- Aedo S, Porcile A, Irribarra C. Calidad de Vida Relacionada con el Climaterio en una Población Chilena de Mujeres Saludables. Rev Chil Obstet Ginecol 2006;71:402–9
- Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 2007;57:271–8
- Goldberg D, Bridges K, Duncan-Jones P, Grayson D. Detecting anxiety and depression in general medical settings. BMJ 1988; 297:897–9
- Montón C, Pérez Echeverria Mi, Campos R, et al. Escalas de Ansiedad y Depresión de Goldberg: Una Guía de Entrevista Eficaz Para la Detección del Malestar Psíquico. Atención Primaria 1993;12:345–9
- International Diabetes Federation. Diabetes Atlas, 5th edn. Brussels, 2012. http://www.idf.org/diabetesatlas/5e/the-global-burden. Accessed: 14/04/2013
- Gruppo di studio Progetto Menopausa Italia. Risk factors for type II diabetes in women attending menopause clinics in Italy: a cross-sectional study. Climacteric 2005;8:287–93
- Olaiz-Fernández G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S. Diabetes mellitus in Mexican adults: results from the 2000 National Health Survey. Salud Pública Méx 2007; 49(Suppl 3):s331–7
- Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway?. Curr Atheroscler Rep 2012;14: 160–6
- Scheen AJ. Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion?. Diabetes Metab 2005;31(Spec No 2):5S27–34
- Kesavadev JD, Short KR, Nair KS. Diabetes in old age: an emerging epidemic. J Assoc Physicians India 2003;5:1083–94
- Seidell JC. Obesity, insulin resistance and diabetes – a worldwide epidemic. Br J Nutr 2000;83(Suppl 1):S5–8
- Kim C, Edelstein SL, Crandall JP, et al.; Diabetes Prevention Program Research Group. Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause 2011;18: 857–68
- Manson JE, Rimm EB, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Ann Epidemiol 1992; 2:665–73
- de Lauzon-Guillain B, Fournier A, Fabre A, et al. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohort. Diabetologia 2009;52: 2092–100
- Pentti K, Tuppurainen MT, Honkanen R, et al. Hormone therapy protects from diabetes: the Kuopio Osteoporosis Risk Factor And Prevention Study. Eur J Endocrinol 2009;160:979–83
- Yoshihara R, Utsunomiya K, Gojo A, et al. Association of polymorphism of estrogen receptor-alpha gene with circulating levels of adiponectin in postmenopausal women with type II diabetes. J AtherosclerThromb 2009;16:250–5
- Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type II diabetes: a systematic review and meta-analysis. JAMA 2009;302:179–88
- Organización Panamericana de la Salud. Guías ALAD de Diagnóstico, Control y Tratamiento de Diabetes Mellitus Tipo II. Washington, DC: OPS, 2008
- Gamboa JL, Garcia-Cazarin ML, Andrade FH. Chronic hypoxia increases insulin-stimulated glucose uptake in mouse soleus muscle. Am J Physiol Regul Integr Comp Physiol 2011;300: R85–91
- Cullmann M, Hilding A, Östenson CG. Alcohol consumption and risk of pre-diabetes and type II diabetes development in a Swedish population. Diabet Med 2012;29:441–52
- Khalil N, Sutton-Tyrrell K, Strotmeyer ES, et al. Menopausal bone changes and incident fractures in diabetic women: a cohort study. Osteoporos Int 2011;22:1367–76
- Dorman JS, Steenkiste AR, Foley TP, et al.; Familial Autoimmune and Diabetes (FAD) Study. Menopause in type I diabetic women: is it premature?. Diabetes 2001;50:1857–62
- Schunk M, Reitmeir P, Schipf S, et al. Health-related quality of life in subjects with and without type II diabetes: pooled analysis of five population-based surveys in Germany. Diabet Med 2012; 29:646–53